Genetic map created of nasopharyngeal cancer

Share this content:

the ONA take:

A team of researchers, directed by Professor H. Phillip Koeffler, Senior Principal Investigator at the Cancer Science Institute of Singapore, have determined the specific mutational signature for nasopharyngeal cancer. 

The researchers reviewed protein and DNA samples from over 100 patients in Singapore diagnosed with nasopharyngeal cancer. The examination revealed a number of genes that were mutated and not previously identified, which could open a door to future therapies targeting these nonfunctioning genes.

Genetic map created of nasopharyngeal cancer
Genetic map created of nasopharyngeal cancer
A team of scientists from Singapore has identified a distinct mutational signature and nine mutated genes associated with nasopharyngeal cancer, paving the way to developing novel therapies for this deadly disease. The research has been published in the journal Nature Genetics
READ FULL ARTICLE From Asian Scientist Magazine
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs